Categories · Health/Science
· Cardio-vascular
· Inflammation/infections/immunity
|
Hip and knee patients who smoked needed more revision surgery. Jump to full article: Arthritis Today , 2012-04-30 Author: Dorothy Foltz-Gray
Intro: Two studies presented at the 2012 annual meeting of the American Academy of Orthopaedic Surgeon highlight the dangers that smoking poses to patients receiving total knee or hip implants.
The first study looked at more than 600 total knee replacements (in patients with an average age of 62), performed between 2005 and 2009 at the Center for Joint Preservation and Replacement at Sinai Hospital of Baltimore, and the Bonutti Clinic of Effingham, Illinois. Among the patients, approximately 115 were smokers.
Jump to full article » |
Categories · Health/Science
· Inflammation/infections/immunity
USA, by State · Pennsylvania
|
Jump to full article: Associated Press (AP), 2012-04-21
|
Categories · Health/Science
· Business (Tobacco)
· Nicotine
· Food/Diet/Obesity
· Inflammation/infections/immunity
Organizations · Star
|
Jump to full article: PR Newswire, 2012-04-12 Author: SOURCE Rock Creek Pharmaceuticals, Inc.
Intro: Rock Creek Pharmaceuticals, Inc., a wholly owned subsidiary of Star Scientific, Inc. (NASDAQ: CIGX), announced that Anatabloc® Unflavored is available as an option on the shopping cart on the Anatabloc® website at https://store.anatabloc.com/products as of today. Anatabloc® Unflavored is a revised formulation containing the same active dietary ingredients in the same dose as our original Anatabloc® product. A significant number of individuals using Anatabloc® communicated to us their interest in an Anatabloc® product without mint flavoring; others expressed an interest in a product that does not contain artificial sugar substitutes. Anatabloc® Unflavored is a formulation that can be used by any current or new users of our Anatabloc® product who wish to avoid sweeteners and flavors. The new formulation is the same as the original with respect to the other ingredients and can be used in the same manner. . . .
As of today, the Anatabloc® Unflavored image appears on the main landing page for the Anatabloc® website. Visitors to the website will be able to purchase Anatabloc® Unflavored at a single, one-time purchase price of $99.99 or as part of our Advantage Club renewal program, at $79.99. Each bottle of Anatabloc® Unflavored will contain 200 tablets.
Curtis Wright, IV, MD/MPH, Senior Vice President and Medical Director of Rock Creek Pharmaceuticals said, "When we received the first request for an alternative formulation, there was never any doubt that we would try to fulfill it, since we anticipated that various consumers would want to have the benefit of using Anatabloc® without artificial flavors or sweeteners. We are very pleased that our production team was able to develop a formulation free of artificial flavors and sweeteners for those customers who either do not care for the mint flavoring or prefer not to use artificial sweeteners for a variety of personal reasons. Our goal in formulating Anatabloc® is to promote health and optimum nutrition
Jump to full article » |
Categories · Health/Science
· Inflammation/infections/immunity
non-USA, by Country · India
|
Jump to full article: Tobacco Induced Diseases (de), 2012-04-03 Author: Kiran Gaur, Neeraj Kasliwal and Rajeev Gupta
Intro: Conclusion
Smoking/tobacco use is significantly associated with greater prevalence of middle and internal ear diseases among middle-aged men in India.
Jump to full article » |
Categories · Health/Science
· Teen Smoking/Youth
· Secondhand Smoke
· Pregnancy
· Asthma
· Inflammation/infections/immunity
|
Jump to full article: Allergy - European Journal of Allergy & Clinical Immunology, 2012-04-03
|
Categories · Health/Science
· Inflammation/infections/immunity
non-USA, by Country · UK
· UK-Scotland
|
Jump to full article: Herald Scotland (The Herald and Sunday Herald) (uk), 2012-03-29
|
Categories · Health/Science
· Teen Smoking/Youth
· Secondhand Smoke
· Asthma
· Women
· COPD
· Inflammation/infections/immunity
|
Jump to full article: News-Medical.net, 2012-03-27
|
Categories · Health/Science
· Teen Smoking/Youth
· Secondhand Smoke
· Asthma
· Women
· COPD
· Inflammation/infections/immunity
|
Jump to full article: ScienceDaily, 2012-03-26
|
Categories · Health/Science
· Teen Smoking/Youth
· Secondhand Smoke
· Asthma
· COPD
· Inflammation/infections/immunity
|
Jump to full article: PediatricSuperSite.com, 2012-03-27
|
Categories · Health/Science
· Teen Smoking/Youth
· Secondhand Smoke
· COPD
· Inflammation/infections/immunity
|
Jump to full article: Pediatric Allergy and Immunology, 2012-03-21
|
Categories · Health/Science
· Skin
· Inflammation/infections/immunity
|
Large study counters prior research suggesting the beverage might raise odds for the skin condition Jump to full article: HealthDay [HealthScout], 2012-03-23 Author: Steven Reinberg
Intro: soriasis because there are hypotheses in the past that caffeine might be an anti-inflammatory," said lead author Dr. Abrar Qureshi, an assistant professor of dermatology at Harvard Medical School in Boston.
"However, we found there was no association between coffee intake and the risk of psoriasis," he said.
These findings agree with other studies that found no association between coffee and this skin condition, the researchers noted.
The reason that there has been an association of psoriasis with coffee may have to do with smoking and alcohol, which are known risk factors for psoriasis, Qureshi said. In the study, those who drank the most coffee also drank the most alcohol and smoked, he said.
Jump to full article » |
Categories · Health/Science
· COPD
· Inflammation/infections/immunity
|
Jump to full article: EurekAlert, 2012-03-21
Intro: The third most deadly disease in the U.S., chronic obstructive pulmonary disease (COPD), appears to be partly driven by the action of immune cells circulating in the blood entering into the tissues of the lungs. UC Davis scientists have discovered that this key process begins in the blood vessels around the large airways in the center of the lung. The discovery helps clarify how smoking can bring about this severe respiratory condition.
The research also identifies a potential new target for directed drug therapy to counter the disease, which kills about three million people a year in the U.S. The study is published online today in the Public Library of Science (PLoS) an open-access public science journal.
"Understanding how a disease begins an important step to develop new therapies, and knowing the mechanism and location of white blood cell recruitment to the lung early on in the development of COPD in this model will allow us to more rapidly screen drugs and determine how they work," said Benjamin Davis, a researcher with the Center for Health and the Environment and the lead study author.
Jump to full article » |
Categories · Health/Science
· COPD
· Inflammation/infections/immunity
|
PLoS ONE Jump to full article: Public Library of Science (PLoS), 2012-03-16
|
Categories · Health/Science
· Hookahs/Shisha / Water Pipes
· Inflammation/infections/immunity
non-USA, by Country · Singapore
|
Jump to full article: Straits Times (sg), 2012-03-22
|
Categories · Health/Science
· Hookahs/Shisha / Water Pipes
· Inflammation/infections/immunity
non-USA, by Country · Singapore
|
Jump to full article: Jakarta Globe (id), 2012-03-22
|